Concepedia

Richard H. Creech

RH

Statistics

Publications

34

Citations

13.9K

H-Index

24

Active since

1974

Affiliations

Dana-Farber Cancer Institute(Current)

Fox Chase Cancer Center

University of Wisconsin Carbone Cancer Center

University of Pennsylvania

Albany Medical Center Hospital

Richard H. Creech is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and chemotherapy.

Publications per year

1974–2003

34

Publications

34

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Martin M. Oken, Richard H. Creech, Douglass C. Tormey et al. · American Journal of Clinical Oncology · 1982 · 11.6K citations

Pharmacy, Oncology, Medical Oncology +8

A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma

Katsutaro Shimaoka, David Schoenfeld, William D. DeWys et al. · Cancer · 1985 · 464 citations · Full text

Medicine, Oncology, Pharmacology +17

A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.

John C. Ruckdeschel, Dianne M. Finkelstein, David S. Ettinger et al. · Journal of Clinical Oncology · 1986 · 343 citations

Medicine, Oncology, Pharmacology +12

Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.

Ernest C. Borden, David A. Amato, Charles Rosenbaum et al. · Journal of Clinical Oncology · 1987 · 296 citations

Medicine, Pharmacology, Pharmacotherapy +10

Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2575, generation V--a randomized comparison of four cisplatin-containing regimens.

John C. Ruckdeschel, Dianne M. Finkelstein, Bernard A. Mason et al. · Journal of Clinical Oncology · 1985 · 108 citations

Medicine, Oncology, Pharmacology +12

1–5 of 34